← All companies

TSHA

Taysha Gene Therapies, Inc.

TSHA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$5.78

-0.10 -1.62%

Key statistics

from XBRL data in SEC filings

Market cap

$1.66B

Revenue (TTM)

$7.47M

Net income (TTM)

-$130M

EPS (TTM)

$-0.38

P/E ratio

—

Dividend yield

—

Free cash flow

-$93.8M

Cash

$277M

Total assets

$300M

Gross margin

—

52-week range

$2.54 – $7.30

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Other events Jun 25, 2026 8-K Regulation FD disclosure; Other events Jun 22, 2026 8-K Shareholder vote results Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Entered a material agreement; Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Other events Oct 16, 2025 8-K Other events Oct 9, 2025 8-K Other events Oct 2, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 3, 2025 8-K Entered a material agreement; Other events May 29, 2025 8-K/A Regulation FD disclosure; Other events May 29, 2025 8-K Regulation FD disclosure; Other events May 28, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Entered a material agreement; Other events Jun 26, 2024 8-K Results of operations (earnings release); Other events Jun 26, 2024 8-K Regulation FD disclosure Jun 18, 2024 8-K Shareholder vote results May 30, 2024 8-K Results of operations (earnings release) May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) Mar 19, 2024 10-K Fiscal year ended 2023-12-31 Mar 19, 2024 8-K Regulation FD disclosure Jan 10, 2024 8-K Director or officer change Dec 20, 2023 8-K Amended charter or bylaws; Shareholder vote results Nov 15, 2023 8-K Results of operations (earnings release) Nov 14, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Director or officer change Nov 1, 2023